Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-20-063609

Options or other derivatives

  • Chief Executive Officer acquired 350,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lynch Casey Chief Executive Officer 2020-12-11 Grant or award · Stock Option (Right to Buy) +175,000 175,000 D: show line 1 in the form
Lynch Casey Chief Executive Officer 2020-12-11 Grant or award · Stock Option (Right to Buy) +175,000 175,000 D: show line 2 in the form
Loading xslF345X03/doc4.xml…